Clinical trialNCT05559164RecruitingPhase 2Interventional

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

SponsorRutgers, The State University of New JerseyEnrollment60Cardiac ToxicityEarly-stage Breast Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-III HER2 positive breast being treated with anti-HER2 therapy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mridula George, MD
Rutgers Cancer Institute of New Jersey
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Trinitas Hospital and Comprehensive Cancer Center
Elizabeth, New Jersey, United States
Recruiting
Rwjbarnabas Health - Robert Wood Johnson University Hospital, Hamilton
Hamilton, New Jersey, United States
Recruiting
Rwjbarnabas Health - - Jersey City Medical Medical
Jersey City, New Jersey, United States
Recruiting
Monmouth Medical Center Southern Campus
Lakewood, New Jersey, United States
Recruiting
Monmouth Community Medical
Long Branch, New Jersey, United States
Recruiting
Rwjbarnabas Health - Monmouth Medical Center
Long Branch, New Jersey, United States
Recruiting
Rwjbarnabas Health - Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
Not, yet, recruiting
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Recruiting
Rwjbarnabas Health - Newark Beth Israel Medical Center
Newark, New Jersey, United States
Recruiting
Rwjbarnabas Health - Robert Wood Johnson University Hospital
Somerset, New Jersey, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Lipitor 40mg Tablet

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Sept 2022
Primary completion: 1 Sept 2026
Completion: 1 Mar 2027
Last update posted: 14 Nov 2025
Registered enrollment: 60
Registry id: NCT05559164

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.